Wilmer Eye Institute, Johns Hopkins University School of Medicine, Johns Hopkins Hospital, 600 N Wolfe St, Baltimore, MD, 21287, USA.
Division of Medical Microbiology, Department of Pathology, The Johns Hopkins School of Medicine, Baltimore, MD, USA.
Graefes Arch Clin Exp Ophthalmol. 2022 Aug;260(8):2585-2590. doi: 10.1007/s00417-022-05639-0. Epub 2022 Mar 31.
Increased ophthalmology-specific risk of novel coronavirus 2019 (SARS-CoV-2) transmission is well-established, increasing the fear of infection and causing associated decreased rates of procedures known to save vision. However, the potential transmission from exposure to clinic instrumentation is unknown, including which additional pathogens may be spreading in this context. This study seeks to fill this gap by characterizing the microbiota of instrumentation in ophthalmology clinics during the COVID-19 pandemic and identifying potential sources of pathogenic spread encountered by patients and healthcare workers.
Thirty-three samples were captured using standard cultures and media. Ten positive and negative controls were used to confirm proper technique. Descriptive statistics were calculated for all samples. Samples were collected from the retina (N = 17), glaucoma (N = 6), cornea (N = 6), and resident (N = 4) clinics with rigorous disinfection standards at a tertiary academic medical center. Standard media cultures and/or polymerase chain reaction (PCR) was performed for each sample.
From 33 samples, more than half (17/33, 51.5%) yielded bacterial growth. Using two different molecular methods, three samples (3/33, 9%) tested positive for SARS-CoV-2 (cycle thresholds 36.48, 37.14, and 37.83). There was no significant difference in bacterial growth (95% confidence interval [95% CI]: - 0.644-0.358, p = 0.076) among different clinics (retina, glaucoma, cornea, resident). Staphylococcus (S.) epidermidis grew most frequently (12/35, 34%), followed by S. capitis (7/35, 20%), Micrococcus luteus (2/35, 5.7%), Corynebacterium tuberculostearicum (2/35, 5.7%), and Cutibacterium ([C.], Propionibacterium) acnes (2/35, 5.7%). C. acnes growth was more frequent with imaging device forehead rests (2/7, 28.6%) than other surfaces (0/26, 0%, 95% CI: 0.019-0.619, p = 0.040). No samples isolated fungus or adenovirus.
Most samples across subspecialty clinic instrumentation grew bacteria, and several tested positive for SARS-CoV-2. Many isolated pathogens have been implicated in causing infections such as endophthalmitis, conjunctivitis, uveitis, and keratitis. The clinical implications of the ophthalmology microbiome for transmitting nosocomial infections warrant optimization of disinfection practices, strategies for mitigating spread, and additional study beyond the pandemic.
新型冠状病毒 2019(SARS-CoV-2)传播的眼科特异性风险增加已得到充分证实,这增加了感染的恐惧,并导致已知可挽救视力的手术减少。然而,目前尚不清楚从接触诊所仪器设备中传播的潜在风险,包括在这种情况下可能传播哪些其他病原体。本研究旨在通过描述眼科诊所仪器设备中的微生物群,并确定患者和医护人员遇到的潜在致病性传播源,来填补这一空白。
使用标准培养物和培养基采集了 33 个样本。使用 10 个阳性和阴性对照来确认正确的技术。对所有样本进行了描述性统计分析。在一家三级学术医疗中心,对视网膜(N=17)、青光眼(N=6)、角膜(N=6)和住院医师(N=4)诊所进行了样本采集,这些诊所采用严格的消毒标准。对每个样本进行了标准的培养基培养和/或聚合酶链反应(PCR)检测。
在 33 个样本中,超过一半(17/33,51.5%)有细菌生长。使用两种不同的分子方法,有 3 个样本(3/33,9%)检测出 SARS-CoV-2 呈阳性(循环阈值为 36.48、37.14 和 37.83)。不同科室(视网膜、青光眼、角膜、住院医师)的细菌生长无显著差异(95%置信区间[95%CI]:-0.644-0.358,p=0.076)。表皮葡萄球菌(S. epidermidis)生长最频繁(12/35,34%),其次是头状葡萄球菌(S. capitis)(7/35,20%)、微球菌(M. luteus)(2/35,5.7%)、结核棒状杆菌(C. tuberculostearicum)(2/35,5.7%)和痤疮丙酸杆菌(C. acnes)(2/35,5.7%)。与其他表面(0/26,0%,95%CI:0.019-0.619,p=0.040)相比,成像设备额托(2/7,28.6%)上的 C. acnes 生长更为频繁。没有样本分离出真菌或腺病毒。
大多数亚专科诊所仪器设备的样本都生长有细菌,并且有几个样本检测出 SARS-CoV-2 呈阳性。许多分离出的病原体已被认为可引起眼内炎、结膜炎、葡萄膜炎和角膜炎等感染。眼科微生物组在传播医院获得性感染方面的临床意义需要优化消毒实践、制定减轻传播的策略,并在大流行之外进行进一步研究。